FDA Approves CBD Cannabis Drug Epidolex for Treating Epilepsy
In a widely expected move, the United States Food and Drug Administration today announced their approval of Epidiolex, a drug
Read more
FDA
FDA Warns CBD Oil Companies to Stop Selling CBD
Nov 2, 2017 — The Food and Drug Administration (FDA) sent a warning letter to four CBD distributors warning them
Read more
DEA Administrator Says ‘Marijuana Is Not Medicine’
By William Stash Jones Oregon Cannabis Connection May 26, 2017—In a statement at the lauded Cleveland Clinic, Drug Enforcement
Read more
DEA Approves Syndros® Cannabis Oral Solution as Schedule II
By William Stash Jones Oregon Cannabis Connection. March 23, 2017— A new pharmaceutical drug produced by the company Insys has
Read more
The DEA Issues Memo—Hemp Derived CBD is a Schedule I Drug and Always Was
By Keith Mansur Oregon Cannabis Connection. After weeks of upheaval and many arguments in the cannabis and hemp industry
Read more